Cyclooxygenase-2 Is Upregulated in Inflamed Gingival Tissues

Journal of Periodontology

Volumn 72, Issue 4, 2001, Pages 461-469

  Morton, Rakhi Sinha ^b   Dongari Bagtzoglou, Anna I ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE

Author keywords

Cyclooxygenase; Inflammation; Periodontal diseases pathogenesis; Prostaglandins adverse effects

Indexed keywords

COLORING AGENT; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; DIAGNOSTIC AGENT; ENZYME INHIBITOR; EOSIN; FLUORESCENT DYE; HEMATOXYLIN; INTERLEUKIN 1; ISOENZYME; MEMBRANE PROTEIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PEROXIDASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN; SULFONAMIDE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; BACTEROIDES; BIOPSY; CELL CULTURE; COMPARATIVE STUDY; CONNECTIVE TISSUE CELL; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM; ENZYMOLOGY; EPITHELIUM; FIBROBLAST; GENE EXPRESSION; GENETICS; GINGIVA; GINGIVITIS; HUMAN; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY; STATISTICS; UPREGULATION; WESTERN BLOTTING;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; BACTEROIDES; BIOPSY; BLOTTING, WESTERN; CELLS, CULTURED; COLORING AGENTS; CONNECTIVE TISSUE CELLS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYCLOSPORINE; DINOPROSTONE; ENDOTHELIUM; ENZYME INHIBITORS; EOSINE YELLOWISH-(YS); EPITHELIUM; FIBROBLASTS; FLUORESCENT DYES; GENE EXPRESSION; GINGIVA; GINGIVITIS; HEMATOXYLIN; HUMANS; INTERLEUKIN-1; ISOENZYMES; MEMBRANE PROTEINS; NITROBENZENES; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STATISTICS; STATISTICS, NONPARAMETRIC; SULFONAMIDES; UP-REGULATION;

EID: 0035318704     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2001.72.4.461     Document Type: Article

References (57)

1. Whittle BJR, Higgs GA, Eakins KE, Moncada S, Vane JR. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 1980;284:271-273.
2. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976;263:663-665.
3. Davies P, Bialey PJ, Goldberg MM. The role of arachidonic acid oxygenation products in pain and inflammation. Ann Reu Immunol 1984;2:335-357.
4. Ferreira SH, Vane JR. Prostaglandins: Their disappearance from and release into the circulation. Nature 1967; 216:868-873.
5. Ikeda K, Tanaka K, Katori M. Potentiation of bradykinin-induced vascular permeability increase by prostaglandin E2 and arachidonic acid in rabbit skin. Prostaglandins 1975;10:747-758.
6. 2 in rat and human skin. Br J Pharm 1976;56:229-233.
7. 2 levels and human periodontal disease. Prostaglandins 1974;6:81-85.
8. 2 in human gingiva in health and disease and its stimulation by female sex steroids. Prostaglandins 1976;11:331-341.
9. 2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. J Clin Periodontol 1994;21:327-333.
10. Offenbacher S, Odle BM, Gray RC, Van Dyke TE. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adults and juvenile periodontitis patients. J Periodont Res 1984;19:1-13.
11. Birkedal-Hansen H. Role of cytokines and inflammatory mediators. J Periodont Res 1993;28:500-510.
12. Dietrich JW, Goodson JM, Raisz LG. Stimulation of bone resorption by various prostaglandins. Prostaglandins 1975;10:231-237.
13. 2 on macrophages and osteoclasts in cultured fetal long bones. Cell Tissue Res 1980;207:341-346.
14. Homo F, Russo-Marie F, Paiernik M. Prostaglandin secretion by human thymic epithelium: in vitro effects of steroids. Prostaglandins 1981;22:377-385.
15. Rosenbaum L, Cheli CD, Gerritsen ME. Dexamethasone inhibits prostaglandin release from coronary microvessel endothelium. Am J Physiol 1986;250:970-977.
16. 2 secretion, cell maturation and CD14 expression by monocyte-derived macrophage from localized juvenile periodontitis patients. J Periodontol 1996;67:224-228.
17. 2 secretion by human periodontal ligament and gingival fibroblasts. Arch Oral Biol 1985;33:237-243.
18. Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ, Trifan OC. Cyclooxygenase-1 and -2 isoenzymes. Int J Biochem Cell Biol 1999;31:551-557.
19. Needleman P, Isakson PC. The discovery and function of COX-2. J Rheumatol 1997;24(Suppl. 49):6-7.
20. Seibert K. Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor 1994;4:17-23.
21. Smith WL. The eicosanoids and their biochemical mechanism of action. Biochem J 1989;259:315-324.
22. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB 1998;12:1063-1073.
23. Crofford LJ. COX-2 in synovial tissues. Osteoarthritis Cartilage 1999;7:406-408.
24. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci (USA) 1992;82:7384-7388.
25. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993;268:9049-9054.
26. Lee SH, Soyoola E, Chanmugam P, et al. Selective expression of mitogen-inducible cyclooxygenase in macrophage stimulated with lipopolysaccharide. J Biol Chem 1992;276:25934-25938.
27. Newell J, Irwin CR. Comparative effects of cyclosporin on glycosaminoglycan synthesis by gingival fibroblasts. J Periodontol 1997;68:443-447.
28. Newton RC, Covington M. The activation of human fibroblast prostaglandin E production by interleukin 1. Cell Immunol 1987;110:338-349.
29. Richards D, Rutherford RB. The effects of interleukin 1 on collagenolytic activity and prostaglandin-E secretion by human periodontal-ligament and gingival fibroblast. Arch Oral Biol 1988;33:237-243.
30. Noguchi K, Shitashige M, Yanai M, et al. Prostaglandin production via induction of cyclooxygenase by human gingival fibroblasts stimulated with lipopolysaccharides. Inflammation 1996;20:555-568.
31. Dongari-Bagtzoglou AI, Ebersole JL. Increased presence of interleukin-6 (IL-6) and IL-8 secreting fibroblast subpopulations in adult periodontitis. J Periodontol 1998; 69:899-910.
32. Martin M, Neumann D, Hoff T, Resch K, DeWitt D, Goppelt-Struebe M. Interleukin-1 induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Inter 1994;45:150-158.
33. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994;47: 55-59.
34. Sano H, Hla T, Maier JA, et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and strepptococcal cell wall arthritis. J Clin Invest 1992;89:97-108.
35. Hendle J, Nielsen OH. Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol 1997;92:1170-1173.
36. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterol 1998;115:297-306.
37. Siegle I, Klein T, Backman JT, Saal JG, Nsing RF, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue. Arthritis Rheum 1998;41: 122-129.
38. Kang RY, Freire-Moar J, Sigal E, Chu C-Q. Expression of cyclooxygenase-2 in a human and an animal model of rheumatoid arthritis. Br J Rheumatol 1996;35:711-718.
39. 1 in a colonic epithelial cell line. J Clin Invest 1985;76:1828-1836.
40. 2 prostaglandins modulate cell proliferation in the intestinal epithelium of the rat. Digestion 1992;52:157-164.
41. Dayer JM, Krane SM, Russell RG, Robinson DR. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci (USA) 1976;73:945-949.
42. Robinson DR, Tashjian AH Jr, Levine L. Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 1975;56:1181-1188.
43. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-87.
44. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1996;1:821-878.
45. Smith WL, DeWitt DL. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995;15:179-194.
46. Appley SB, Ristimaki A, Neilson K, Narko K, Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem J 1994;302(Pt 3):723-727.
47. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 1997;24 (Suppl. 49):15-19.
48. 2 production in human gingival fibroblasts stimulated with interleukin-1β and epidermal growth factor. Biochem Biophys Res Commun 1999;257:528-532.
49. O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci (USA) 1992;89:4888-4892.
50. Pritchard KA, O'Banion MK, Miano JM, et al. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem 1994;269:8504-8509.
51. Williams RC, Jeffcoat MK, Howell H, et al. Altering the progression of human alveolar bone loss with non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989;60:485-490.
52. Abramson MM, Wolff LF, Offenbacher S, Aeppli DM, Hardie ND, Friedman HM. Flurbiprofen effect on gingival crevicular fluid prostaglandin and thromboxane levels in humans. J Periodont Res 1992;27:539-543.
53. Jeffcoat MK, Williams RC, Reddy MS, English R, Goldhaber P. Flurbiprofen treatment of human periodontitis: effect in alveolar bone height and metabolism. J Periodont Res 1988;23:381-385.
54. Cheatum DE, Arvanitakis C, Gumpel M, Stead H, Geis GS. An endoscopic study of gastroduodenal lesions induced by nonsteriodal anti-inflammatory drugs. Clin Therapy 1999;21:992-1003.
55. Vane J. Toward a better aspirin. Nature 1994;367:215-216.
56. Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 1998;47(Suppl. 2): S78-S87.
57. Lipsky PE, Isakson PC. Outcome of specific COX-2 inhibition in rheumatoid arthritis. J Rheumatol 1997;24 (Suppl. 49):9-14.